Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Ophthalmology. 2019 Mar 20;126(8):1084–1089. doi: 10.1016/j.ophtha.2019.03.020

Table 3.

Adverse events by treatment group

No. (%)
Adverse Event Standard Therapy
(N = 35)
Intrastromal Voriconazole
(N = 35)
P-value
Endophthalmitis 2 (6) 0 (0)
Glaucoma 2 (6) 4 (11)
Hypopyon 0 (0) 3 (9)
Medication reaction 1 (3) 0 (0)
Non-healing ulcer 0 (0) 3 (9)
Perforation 3 (9) 8 (23)
Progressive corneal thinning 0 (0) 1 (3)
Therapeutic penetrating 13 (37) 14 (40)
keratoplasty
Total 21 33 0.81a
a

Fisher’s exact comparing number of people with any adverse event in each arm

Abbreviations: No. = number